Stay updated on Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:02:43.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed study protocols and eligibility criteria for a clinical trial on pembrolizumab in metastatic triple negative breast cancer, while adding a new version revision and the name of a collaborator.
    Difference
    41%
    Check dated 2025-04-16T10:33:45.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 10, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T05:12:23.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page has updated its last update date to March 2025, reflecting a shift in the timeline for content relevance. Additionally, previous update dates from February 2024 have been removed.
    Difference
    0.9%
    Check dated 2025-03-11T00:33:14.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:25:21.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:49:13.000Z thumbnail image

Stay in the know with updates to Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page.